Esmael, Mampai M.

HRN: 10-78-19  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/29/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/29/2024
04/04/2024
IV
500 Mg
Q 8 Hours
Obstruction
Checking Final Appropriateness 
03/29/2024
CEFTRIAXONE 1G (VIAL)
03/29/2024
04/04/2024
IV
2 Grams
OD
Obstruction
Checking Final Appropriateness 
04/20/2024
CEFTRIAXONE 1G (VIAL)
04/20/2024
04/26/2024
IV
2g
Q24
Direct Ingunal Hernia Incarcerated
Waiting Final Action 
04/20/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/20/2024
04/27/2024
IV
500mg
Q8H
Incarcerated Direct Inguinal Hernia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: